rosiglitazone has been researched along with Cushing Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leal-Cerro, A; León Justel, A; Mangas, MA; Soto Moreno, A; Webb, S | 1 |
| Batista, MM; Carvalho, VF; Cordeiro, RS; E Silva, PM; Martins, MA; Pons, AH; Silva, AR; Torres, RC | 1 |
| Ambrosi, B; Arosio, M; Beck-Peccoz, P; Cannavo, S; Chiodini, I; Dall'Asta, C; Epaminonda, P; Ferrero, S; Libe, R; Trimarchi, F; Vigo, T | 1 |
| Atkinson, AB; Hull, SS; Sheridan, B | 1 |
| Becker, C; Bierhaus, A; Bode, H; Fohr, B; Hamann, A; Hammes, HP; Humpert, P; Kasperk, C; Morcos, M; Nawroth, PP; Pfisterer, F; Schilling, T; Schwenger, V; Tafel, J; Zeier, M | 1 |
1 review(s) available for rosiglitazone and Cushing Syndrome
| Article | Year |
|---|---|
[The medical management of Cushing's syndrome].
Topics: Adrenal Cortex; Adrenalectomy; Adrenocorticotropic Hormone; Aminoglutethimide; Combined Modality Therapy; Cushing Syndrome; Dopamine Agonists; Glucocorticoids; Humans; Hydrocortisone; Hypophysectomy; Imidazoles; Mitotane; Pituitary Gland, Anterior; Rosiglitazone; Somatostatin; Thiazolidinediones | 2009 |
2 trial(s) available for rosiglitazone and Cushing Syndrome
| Article | Year |
|---|---|
Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Cushing Syndrome; Diabetes Mellitus, Type 2; Female; Humans; Hydrocortisone; Hypoglycemic Agents; Immunohistochemistry; Ligands; Male; Middle Aged; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors; Treatment Outcome | 2004 |
Long-term treatment of central Cushing's syndrome with rosiglitazone.
Topics: Adrenocorticotropic Hormone; Cushing Syndrome; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hydrocortisone; Hypoglycemic Agents; Male; Rosiglitazone; Salvage Therapy; Thiazolidinediones; Treatment Outcome | 2007 |
2 other study(ies) available for rosiglitazone and Cushing Syndrome
| Article | Year |
|---|---|
Activation of PPARγ by restores mast cell numbers and reactivity in alloxan-diabetic rats by reducing the systemic glucocorticoid levels.
Topics: Animals; Apoptosis; Cell Count; Cell Differentiation; Cell Proliferation; Cushing Syndrome; Diabetes Mellitus, Experimental; Glucocorticoids; Male; Mast Cells; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2012 |
Pre-operative medical therapy with rosiglitazone in two patients with newly diagnosed pituitary-dependent Cushing's syndrome.
Topics: Adult; Cushing Syndrome; Female; Humans; Middle Aged; Pituitary Neoplasms; Rosiglitazone; Thiazolidinediones | 2005 |